期刊文献+

全内镜下甲状腺切除术治疗分化型甲状腺癌25例 被引量:10

Endoscopic thyroidectomy for differentiated thyroid carcinoma: report of 25 cases
原文传递
导出
摘要 目的 总结全内镜下甲状腺切除术治疗分化型甲状腺癌的经验并评估其治疗效果.方法 回顾性分析自2004年11月至2009年7月行乳晕腋窝入路全内镜下甲状腺癌手术25例患者的临床资料. 结果全部25例患者均在全内镜下成功实施甲状腺根治性手术,11例行患侧腺叶全切,14例行患侧腺叶全切加峡部及对侧腺叶大部分切除;7例术中清扫淋巴结.术后病理诊断均证实为分化型甲状腺癌(乳头状癌23例,滤泡状癌2例),中位随访时间28.0月(5~58月),无手术并发症,无复发病例,全部患者对美容效果满意.结论 内镜下甲状腺切除手术治疗分化型甲状腺癌是一种兼顾安全性,可行性及美容性的方法. Objective To summarize the experience of totally endoscopic thyroidectomy (TET) in treating differentiated thyroid carcinoma and to evaluate its feasibility, safety and the therapeutic result.Methods The clinical data of 25 cases of thyroid carcinoma treated with TET via the areola of breast or by axillary approach from November 2004 to July 2009 in our hospital were retrospectively analyzed.Result TET procedures were successfully performed in all 25 cases. Postoperative pathology confirmed that 23 cases were of papillary cancer and the other 2 were follicle cancer. Lobectomy and subtotal thyroidectomy were performed in 11and 14 cases respectively. In 7 cases additional lymph node dissection was performed.All the cases were followed-up, ranging from 5 to 58 months, with a median of 28 months. No recurrence was found during this period. There was no morbidity nor major complications and patients were all satisfied with the cosmetic effect. Conclusion Totally endoscopic thyroidectomy (TET) is curative, safe and cosmetic therapy for differentiated thyroid carcinoma.
出处 《中华普通外科杂志》 CSCD 北大核心 2010年第8期624-626,共3页 Chinese Journal of General Surgery
关键词 甲状腺肿瘤 甲状腺切除术 内窥镜 Thyroid neoplasms Thyroidectomy Endoscopes
  • 相关文献

参考文献9

  • 1曹利平,林辉.微创甲状腺切除的发展现状[J].中国微创外科杂志,2005,5(1):37-39. 被引量:46
  • 2Ochiai R,Takeda J,Noguchi J,et al.Subcutaneous carbon dioxide insufflation does not cause hypercarbia during endoscopic thyroidectomy.Anesth Analg,2000,90:760-762.
  • 3Hundahl SA,Cady B,Cunningham MP,et al.Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996.Cancer,2000,89:202-217.
  • 4Cady B.Our AMES is true:how an old conception still hits the mark or risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer.Am J Surg,1997,174:462-468.
  • 5王深明.甲状腺外科的进展与热点问题[J].中国实用外科杂志,2003,23(3):174-180. 被引量:102
  • 6Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2006,16:109-142.
  • 7Noguchi S,Yamashita H,Uchino S.Modified radical neck dissection is better than partial dissection of lymph nodes.World J Surg,2009,33:394-396.
  • 8Miccoli P,Materazzi G,Ambrosini CE,et al.Video-assisted central compartment lymphadenectomy in a patient with a positive RET oncogene:initial experience.Surg Endosc,2007,21:120-123.
  • 9Bellantone R, Lombardi CP, Raffaelli M, et al. Central neck lymph node removal during minimally invasive video-assisted thyroidectomy for thyroid carcinoma: a feasible and safe procedure. Laparoendosc Adv Surg Tech,2002,12 : 181-185.

二级参考文献45

  • 1[12]Lazarus JH, Obuobie K. Thyroid disorder-an update. Postgrad Med J, 2000, 76(899): 529
  • 2[13]Quadro L, Panariello L, Salvatore D, et al. Frequent RET proto-oncogene mutations in multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab, 1994, 79(2): 590
  • 3[14]Bongarzone I, Pierotti MA, Monzini N,et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene, 1989, 4(12): 1457
  • 4[15]Chung JK. Sodium iodide symporter: its role in nuclear medicine. J Nucl Med, 2002, 43(9): 1188
  • 5[1]Mishra A, Agarwal A, Agarwal G, et al. Total thyroidectomy for benign thyroid disorders in an endemic region. World J Surg, 2001, 25(3): 307
  • 6[2]Gimm O, Brauckhoff M, Thanh PN, et al. An update of thyroid surgery. Eur J Nucl Med, 2002, 29(supple 2): s447
  • 7[3]Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med, 1994, 97(5): 418
  • 8[4]Samaan NA, Schultz PN, Hickey RC, et al. The results of various modalities of carcinoma: a retrospective review of 1599 patients. J Clin Endocrinol Metab, 1992, 75(3): 714
  • 9[5]Udelsman RA. Differentiated thyroid cancer: less than total thyroidectomy. Ann Surg Oncol, 2000, 7(5): 382
  • 10[6]Shaha AR. Differentiated thyroid cancer: less than total thyroidectomy. Ann Surg Oncol. 2000, 7(5): 379

共引文献146

同被引文献81

  • 1苏洋,吴硕东.腔镜下甲状腺手术并发症临床分析(附23例报告)[J].中国内镜杂志,2007,13(7):684-686. 被引量:10
  • 2赵蕊,杨华,顾玮瑾,蔡宏.我国恶性肿瘤手术中无瘤操作技术的进展[J].中华护理杂志,2007,42(8):730-732. 被引量:60
  • 3王庆兆,魏韬哲.现代甲状腺外科学[M].郑州:河南医科大学出版社,2009:254-255.
  • 4Ohgami M,Ishii S,Afisawa,et al.Scarless endoscopicthyroidectomy:breast approach for better cosmesis[J].Surg Laparosc EndoscPercutan Tech,2000,10(1):1-4.
  • 5王存川,张清河.普通外科腔镜手术的现状与进展:腔镜甲状腺手术现状[J].中国医师进修杂志(外科版),2007,30(9):1-2. 被引量:7
  • 6Schlumberger M, Sherman SI. Approach to the patient with ad- vanced differentiated thyroid cancer[ J]. Eur J Endocrinol, 2012, 166(1 ) :5-11.
  • 7Toniato A, Boschin I, Casara D, et al. Papillary thyroid carcino- ma: factors influencing recurrence and survival[J]. Ann Surg On- col, 2008, 15(5) :1518-1522.
  • 8NCCN. Clinical practice guidelines in oncology: thyroid carcinoma [S/OL]. Version 1. 2011. http://www, nccn. org/profession- als/physician_gls/pdf/thyroid, pdf.
  • 9American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J ]. Thyroid, 2009, 19 ( 11 ) : 1167-1214.
  • 10The Japanese Society of Thyroid Surgery/The Japanese Association of Endocrine Surgeons. (2010) Guidelines for management of thyroid tumor[ M ]. Kanehara Press :Tokyo, 2010.

引证文献10

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部